MARLBOROUGH, Mass--Cytyc Corporation's ThinPrep 2000 System for
cervical cancer screening has received FDA approval and is now
available. The system offers an improved method of preparing Pap
smears over the conventional method, leading to fewer retests
due to compromised smears and potentially fewer missed abnormalities.
With the ThinPrep Pap test, the physician collects the cervical
cells in the traditional way, but rather than smearing a small
portion of the cells onto a slide, the physician rinses the cells
from the collection device into a vial filled with preservative
solution. This vial is then sent to the lab where the ThinPrep
2000 Processor disperses and filters its contents to reduce mucus,
blood, and inflammation, and applies a thin, even layer of cells
to a microscope slide.